Author:
Snodgrass Wayne R.,Hsu Chia Wei
Publisher
Springer International Publishing
Reference74 articles.
1. Mowry JB, Spyker DA, Cantilena LR, et al. 2013 Annual report of the American Association of Poison Control Centers National Poison Data System (NPDS). Clin Toxicol. 2013;52:1032–283.
2. Nau H, Loscher W. Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia. 1984;15 Suppl 1:s14–22.
3. Tatsuhara T, Muro H, Matsuda Y, Imai Y. Determination of valproic acid and its metabolites by gas chromatography–mass spectrometry with selected ion monitoring. J Chromatogr. 1987;399:183–95.
4. Sadeque AJ, Fisher MB, Korzekwa KR, et al. Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-en-valproic acid. J Pharmacol Exp Ther. 1997;293:698–703.
5. Neuman MG, Shear NH, Jacobson-Brown PM, et al. CYP2E1-mediated modulation of valproic acid-induced hepatotoxicity. Clin Biochem. 2001;34:211–8.